Donor germ-line variants associate with outcomes of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndromes. Am J Hematol 2024 Apr;99(4):770-773
Date
02/10/2024Pubmed ID
38339773Pubmed Central ID
PMC10947828DOI
10.1002/ajh.27243Scopus ID
2-s2.0-85184938817 (requires institutional sign-in at Scopus site)Abstract
Overall survival probability for MDS patients who underwent allo-HCT and were matched to donors that are wild-type (red) and heterozygous (blue) for the rs111224634 SNP.
Author List
Auer PL, Farazi M, Zhang T, Dong J, Bolon YT, Spellman SR, Saber WAuthors
Paul L. Auer PhD Professor in the Institute for Health and Equity department at Medical College of WisconsinJing Dong PhD Assistant Professor in the Medicine department at Medical College of Wisconsin
Wael Saber MD, MS Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Humans
Myelodysplastic Syndromes
Retrospective Studies
Tissue Donors
Transplantation Conditioning